NewTimeSpace News: May 29, 2026, AMASSE CAPITAL(08168.HK) released its Interim Report for the period ended September 30, 2026, Total Revenue stood at HKD 10.85 million, increased by 134.48% YoY
NewTimeSpace News, May 29, 2026, CHINA NEXT-GEN(03928.HK) released its Interim Report for the period ended September 30, 2026, Total Revenue stood at SGD 16.3 million, decreased by 49% YoY
NewTimeSpace News, May 29, 2026, GOLDEN FAITH GP(02863.HK) released its Interim Report for the period ended September 30, 2026, Total Revenue stood at HKD 203.52 million, decreased by 23.62% YoY
NewTimeSpace News: LI AUTO-W(02015.HK) will spend USD 8.49 million to repurchase 1.13 million shares on May 29, 2026.
NewTimeSpace News, May 29, 2026, HATCHER GROUP(08365.HK) released its Interim Report for the period ended September 30, 2026, Total Revenue stood at HKD 32.02 million, decreased by 12.74% YoY
NewTimeSpace News, HORIZONROBOT-W(09660.HK) will spend HKD 117.01 million to repurchase 22.1 million shares on May 29, 2026.
NewTimeSpace News, May 31, 2026, GLOBALSTRAT(08007.HK) released its Interim Report for the period ended September 30, 2026, Total Revenue stood at HKD 307.3 million, increased by 83.19% YoY
By the close of trading on May 29, 2026, DEEPZERO(02723.HK) saw a gain of 27.14% in its share price, closing at HKD 445. During the session, it reached an intraday high of HKD 506 and touched an intraday low of HKD 366.4.
By the close of trading on May 29, 2026, BIREN TECH(06082.HK) saw a gain of 14.67% in its share price, closing at HKD 61.75. During the session, it reached an intraday high of HKD 63.8 and touched an intraday low of HKD 56.
May 29, 2026, LEE KEE(00637.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 1.97 billion, decreased by 4.09% YoY
NewTimeSpace News: Shanghai Henlius Biotech Co., Ltd. (02696.HK) announced that Hanbeiyou (Pertuzumab Injection), independently developed by the company, has obtained marketing approval from the National Medical Products Administration (NMPA). It is indicated for neoadjuvant and adjuvant therapy of HER2-positive early breast cancer, as well as treatment for metastatic breast cancer, covering all approved indications of the reference pertuzumab in mainland China. Pertuzumab generated sales of approximately RMB 2.728 billion in China in 2025.
NewTimeSpace News: On May 29, CapitaLand Ascott Trust announced that it has entered into a sale and purchase agreement with an independent third party to dispose of The Robertson House by The Crest Collection located on Unity Street, Singapore, at a consideration of SGD 360 million, exclusive of GST.
NewTimeSpace News: On May 29, Keppel announced that Keppel Sakra Cogen Plant (KSC), Singapore's first hydrogen-ready combined cycle power plant, has officially entered commercial operation.
NewTimeSpace News, APAC RESOURCES (01104.HK) plans to conduct a rights issue on the basis of \\"2 for 1\\", with estimated net proceeds of HKD 1.07 billion.
NewTimeSpace News, FUJING HOLDINGS (02497.HK) plans to issue in total 90.63 million shares.
NewTimeSpace News, NUR HOLDINGS (00254.HK) plans to issue in total 112 million shares by subscription, with estimated net proceeds of HKD 86.14 million.
